Strides Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE939A01011
  • NSEID: STAR
  • BSEID: 532531
INR
873.00
37.4 (4.48%)
BSENSE

Feb 03

BSE+NSE Vol: 5.64 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
1,194.65
1,220.83
1,119.74
1,190.39
1,153.67
1,166.93
1,054.34
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,194.65
1,220.83
1,119.74
1,190.39
1,153.67
1,166.93
1,054.34
Raw Material Cost
459.71
429.76
260.58
269.73
476.58
409.15
320.43
Purchase of Finished goods
71.38
41.80
120.91
231.60
133.77
173.04
149.67
(Increase) / Decrease In Stocks
-68.14
43.71
62.79
-2.36
-130.23
-31.16
-20.25
Employee Cost
229.54
226.78
225.52
222.86
215.64
215.70
208.55
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.01
-0.01
0.00
0.00
0.00
-0.01
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
266.22
247.23
231.86
250.70
247.60
215.61
205.91
Total Expenditure (Excl Depreciation)
958.70
989.27
901.66
972.53
943.36
982.33
864.32
Operating Profit (PBDIT) excl Other Income
235.95
231.56
218.08
217.86
210.31
184.60
190.02
Other Income
106.86
27.14
8.58
11.98
5.62
28.41
12.72
Operating Profit (PBDIT)
342.81
258.70
226.66
229.84
215.93
213.01
202.74
Interest
43.38
46.13
47.46
50.32
52.18
73.82
72.52
Exceptional Items
-3.30
-8.77
-8.37
-27.42
-2.43
-3.87
3,286.49
Gross Profit (PBDT)
296.13
203.80
170.83
152.10
161.32
135.32
228.60
Depreciation
50.62
49.64
48.89
48.86
48.42
48.45
46.52
Profit Before Tax
245.48
153.12
122.04
106.38
113.85
86.21
180.49
Tax
37.35
21.59
16.45
20.76
23.81
13.94
19.02
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
208.15
132.57
105.49
82.49
89.09
72.93
163.05
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
3,188.11
Net Profit
208.15
132.57
105.49
82.49
89.09
72.93
3,351.16
Share in Profit of Associates
-0.03
-1.05
0.10
3.13
0.95
-0.66
-1.58
Minority Interest
6.02
3.99
5.99
3.42
2.09
0.43
-1.89
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
202.11
127.53
99.61
82.19
87.95
71.84
3,351.47
Equity Capital
92.17
92.17
92.16
92.16
92.16
91.96
91.90
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
21.93
13.84
10.81
8.92
9.54
3.42
159.81
Diluted Earnings per share
21.92
13.84
10.81
8.92
9.55
3.42
159.49
Operating Profit Margin (Excl OI)
19.75%
18.97%
19.48%
18.3%
18.23%
15.82%
18.02%
Gross Profit Margin
24.79%
16.69%
15.26%
12.78%
13.98%
11.6%
21.68%
PAT Margin
17.42%
10.77%
9.43%
7.19%
7.8%
6.19%
15.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 3.55% vs 14.71% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 129.80% vs 77.07% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 12.19% vs 48.13% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is -16.86% vs -25.15% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Strides Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,194.65
423.99
770.66
181.76%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,194.65
423.99
770.66
181.76%
Raw Material Cost
459.71
182.79
276.92
151.50%
Purchase of Finished goods
71.38
45.14
26.24
58.13%
(Increase) / Decrease In Stocks
-68.14
-14.83
-53.31
-359.47%
Employee Cost
229.54
81.69
147.85
180.99%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
266.22
73.52
192.70
262.11%
Total Expenditure (Excl Depreciation)
958.70
368.31
590.39
160.30%
Operating Profit (PBDIT) excl Other Income
235.95
55.68
180.27
323.76%
Other Income
106.86
2.15
104.71
4,870.23%
Operating Profit (PBDIT)
342.81
57.83
284.98
492.79%
Interest
43.38
13.51
29.87
221.10%
Exceptional Items
-3.30
-1.70
-1.60
-94.12%
Gross Profit (PBDT)
296.13
42.62
253.51
594.81%
Depreciation
50.62
15.46
35.16
227.43%
Profit Before Tax
245.48
27.16
218.32
803.83%
Tax
37.35
7.56
29.79
394.05%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
208.15
19.60
188.55
961.99%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
208.15
19.60
188.55
961.99%
Share in Profit of Associates
-0.03
0.00
-0.03
Minority Interest
6.02
4.86
1.16
23.87%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
202.11
14.74
187.37
1,271.17%
Equity Capital
92.17
50.33
41.84
83.13%
Face Value
10.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
21.93
0.59
21.34
3,616.95%
Diluted Earnings per share
21.92
0.58
21.34
3,679.31%
Operating Profit Margin (Excl OI)
19.75%
13.13%
0.00
6.62%
Gross Profit Margin
24.79%
10.05%
0.00
14.74%
PAT Margin
17.42%
4.62%
0.00
12.80%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,194.65 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -2.14% vs 9.03% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 3.55% vs 14.71% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 202.11 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 58.48% vs 28.03% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 129.80% vs 77.07% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 235.95 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 1.90% vs 6.18% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 12.19% vs 48.13% in Dec 2024

Quarterly - Interest
Interest 43.38 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -5.96% vs -2.80% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -16.86% vs -25.15% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.75%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support@mojoinfinity.com, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."